Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
221.6 USD | -3.69% |
|
-2.85% | -14.37% |
09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
12/07 | Biogen, Eisai Get Approval for Leqembi in Israel for Treatment of Alzheimer's Disease | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.37% | 3.23TCr | |
+7.40% | 10TCr | |
+7.76% | 4.22TCr | |
+80.54% | 2.98TCr | |
-12.27% | 1.61TCr | |
+2.33% | 1.44TCr | |
-8.56% | 1.2TCr | |
+182.74% | 1.07TCr | |
+4.19% | 889.02Cr | |
-56.23% | 882.67Cr |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Biogen, Eisai Get Approval for Leqembi in Israel for Treatment of Alzheimer's Disease